Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexmedetomidine on cardiovascular response to laryngoscopy and tracheal intubation
IRCT20220424054628N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, sponsored by Isfahan University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on IRCT20220424054628N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220424054628N1.